WO2007016090A2 - Methods and apparatus for reducing protein content in sperm cell extenders - Google Patents
Methods and apparatus for reducing protein content in sperm cell extenders Download PDFInfo
- Publication number
- WO2007016090A2 WO2007016090A2 PCT/US2006/028846 US2006028846W WO2007016090A2 WO 2007016090 A2 WO2007016090 A2 WO 2007016090A2 US 2006028846 W US2006028846 W US 2006028846W WO 2007016090 A2 WO2007016090 A2 WO 2007016090A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sperm cell
- protein
- sperm
- compromised
- extender
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Definitions
- inventive technology disclosed herein relates to methods and apparatus for reducing protein content in sperm cell extenders. More specifically, this inventive technology may involve eliminating the protein content of a cryoprotectant component used in a multiple step sperm cell extension process. The inventive technology may be particularly suited for use in sorted sperm applications.
- Sperm cell extenders may be commonly used in a variety of biological disciplines that require working with sperm cells.
- one discipline that may make extensive use of sperm cell extenders is the field of artificial insemination.
- natural insemination may involve direct male to female insemination
- artificial insemination may typically involve collecting sperm cells from a male, performing a degree of human manipulation of such sperm cells removed from their natural environment, and then inserting the manipulated sperm cells into a female.
- the precise degree of human manipulation may vary depending on the precise nature of the particular application. For example, some human manipulation may simply involve dividing a collected sperm sample into multiple doses for use in multiple insemination events, possibly with multiple female animals. However, other applications may require more intensive human manipulation.
- human manipulation in some applications may involve sorting sperm cells into populations based on characteristics exhibited by sperm cells.
- One such application may include the use of flow cytometery to separate sperm cells into populations of X-chromosonie-bearing and Y-chromosome bearing sperm cells.
- a flow cytometer may typically accomplish such separation by flowing sperm cells entrained in a fluid stream one at a time through an interrogation region, where information about each sperm cell may be obtained.
- Interrogation may typically be accomplished through the use of optics, for example perhaps by intersecting a laser beam with a sperm cell and measuring the resulting light scatter or fluorescence.
- the determination of a sex characteristic perhaps may be made by staining the sperm cells with a fluorescent dye that binds to the DNA within individual sperm cells. When a laser illuminates individual sperm cells, the dye may fluoresce. Sorting of sperm cells according to a sex characteristic may then be accomplished, perhaps by recognizing that sperm cells bearing an X chromosome have more DNA than sperm cells bearing a Y chromosome, thus possibly emitting more fluorescent light when excited by a laser and perhaps allowing the cell to be identified and separated.
- Another example of human manipulation may involve perhaps freezing sperm cells for use at a later time. Freezing sperm cells may often be critical to the effective use of sperm cells, because freezing may preserve at least some degree of the viability of sperm cells for a period of time extended beyond a point at which such viability otherwise may typically become compromised. Such extension of sperm cell viability may be accomplished in freezing techniques perhaps by slowing the metabolism of sperm cells and perhaps extending their useful life accordingly, hi particular, it perhaps may be known that sperm cell metabolism may be slowed by about 50% approximately for every 10 degrees Celsius to which a sperm cell is cooled.
- frozen sperm cells may be packaged in formats convenient for particular applications, for example perhaps as frozen straws, frozen pellets, or other forms of frozen artificial samples. Frozen sperm cells also may lend themselves well to transportation over large distances, for example as where a sperm cell collection facility, sperm cell extension facility, and artificial insemination facility may be widely dispersed at different locations.
- Cryoprotectants also may be an example of a frequently used constituent part of various types of sperm cell extenders. Moreover, cryoprotectants may take a variety of forms in sperm cell extenders. One commonly used cryoprotectant may be glycerol.
- certain sperm cell extenders may contain an "A" fraction without glycerol and a "B" fraction with glycerol. This may allow a sperm cell extender to be prepared in two or more steps, for example, a first step in which sperm cells may be added to the A fraction of a sperm cell extender at perhaps room temperature, followed by a second step in which the sperm cells added to the A fraction are cooled to a lower temperature, and the B fraction containing glycerol added at such a lower temperature.
- glycerol with other sperm cell extender components in such procedures may entail significant drawbacks.
- protein components of sperm cell extenders such as egg yolk may pose complications for the handling of such extenders when present in the B fraction. This may be due to the volumetric bulk that such protein components create in a sperm cell extender. This phenomenon perhaps may be highlighted by the use of egg yolk in the B fraction of a sperm cell extender requiring centrifugation. Centrifugation may be a commonly used technique in various sperm cell applications to concentrate sperm cells.
- the passage of sperm cells through a flow cytometer may tend to dilute the concentration of sperm cells to a lower concentration than that found in nature. This may be because flow cytometers typically may require entraining sperm cells in a sheath fluid, which may add to the volume of material in which sperm cells are contained. Centrifugation may return sperm cells to a higher concentration perhaps by subjecting them to centrifugal forces and concentrating them accordingly.
- Clarification may be accomplished by any of various suitable methods, for example perhaps by filtration. However, all forms of clarification may require a dedication of resources to accomplish. For example, clarification may entail material costs such as filters or other required devices, labor costs which may tie up personnel resources that otherwise could be dedicated elsewhere, time costs which may slow down a sperm cell extension process, and financial costs related to all of the foregoing.
- B fraction of a sperm cell extender may entail a degree of inherent drawbacks.
- preparation of such a B fraction may entail material costs, labor costs, time costs, and financial costs.
- the tendency toward spoliation over time due to the protein content of such a B fraction may further complicate its use.
- B fraction may not keep well, it may require preparation on an as-needed basis, perhaps disrupting schedules and reducing efficiencies that could be realized if the B fraction otherwise could be prepared in large quantities ahead of time. This drawback may be particularly acute in situations where a sperm cell application may require a relatively high ratio of B fraction to A fraction.
- the inventive technology relates to methods and apparatus for reducing protein content in sperm cell extenders and may include one or more of the following features: techniques for reducing protein content in a sperm cell extender; techniques for reducing protein content in a cryoprotectant-containing B fraction of a sperm cell extender; techniques for preparing sperm cell extenders that do not require clarification; techniques for preparing low density gradient sperm cell extenders suitable for centrifugation; techniques for reducing protein content between individual steps in preparing a sperm cell extender, and techniques for establishing novel values of reduced protein content in sperm cell extenders. Accordingly, the objects of the methods and apparatus for reducing protein content in sperm cell extenders described herein address each of the foregoing problems in a practical manner. Naturally, further objects of the invention will become apparent from the description and drawings below.
- Fig.2a is a depiction of a prior art sperm cell extender.
- Fig.2b is a depiction of an unclarif ⁇ ed centrifugation medium.
- Fig. 3 is a representation of an intermediate sperm cell extender.
- the present inventive technology includes a variety of aspects, which may be combined in different ways.
- the following descriptions are provided to list elements and describe some of the embodiments of the present inventive technology. These elements are listed with initial embodiments, however it should be understood that they may be combined in any manner and in any number to create additional embodiments.
- the variously described examples and preferred embodiments should not be construed to limit the present inventive technology to only the explicitly described systems, techniques, and applications. Further, this description should be understood to support and encompass descriptions and claims of all the various embodiments, systems, techniques, methods, devices, and applications with any number of the disclosed elements, with each element alone, and also with any and all various permutations and combinations of all elements in this or any subsequent application.
- some embodiments may include a method for freezing sorted sperm cells compromised by a sorting event.
- sorting event may be understood to include any of a variety of events in which sperm cells are sorted based on a discrimination of characteristics retained by such sperm cells, which may include in various embodiments immunosexing techniques, buoyancy techniques, or perhaps even flow cytometery techniques.
- compromised may be understood to include any effect of a sorting event that may tend to adversely affect any desired aspect for which the sperm cells may be used, including for example sperm cell viability, sperm cell fecundity, or perhaps even sperm cell longevity.
- freezing may be understood to include any technique for preserving sperm cells that includes depressing their temperature below
- embodiments may involve obtaining a plurality of sperm cells, subjecting such a plurality of sperm cells to sorting stresses, and selecting such a plurality of sperm cells for a desired characteristic.
- obtaining it may be understood that any of various known techniques for obtaining sperm cells may be used, for example perhaps including manual techniques or techniques involving an artificial vagina.
- sorting stresses may be understood to include stresses that sperm cells may experience as a result of a sorting event, and subjecting sperm cells to sorting stresses may include perhaps merely accomplishing a sorting event.
- Certain embodiments may involve cooling a first extended sperm cell mixture to about 5 degrees Celsius.
- a protein-free cryoprotectant- containing sperm cell extender may be added to such a first cooled extended sperm cell mixture in some embodiments to form a second cooled extended sperm cell mixture.
- the term second cooled extended sperm cell mixture may be understood to include the combination of such a first cooled extended sperm cell mixture with such a protein-free cryoprotectant-containing sperm cell extender.
- Various embodiments may also include freezing such a second cooled extended sperm cell mixture.
- a first extended sperm cell mixture in some embodiments may contain a percentage of egg yolk. This may be a function, for example, of the amount of protein contained within a protein-containing sperm cell extender added to a plurality of selected sperm cells, wherein such a protein may be egg yolk.
- the percentage of egg yolk contained within a first extended sperm cell mixture may include more than about .8 percent egg yolk, more than about 1.6 percent egg yolk, more than about 3.2 percent egg yolk, or perhaps even more than about 6.4 percent egg yolk.
- Some embodiments may include a percentage of egg yolk contained within a first extended sperm cell mixture of about 3.2 percent.
- a second cooled extended sperm cell mixture in some embodiments also may contain a percentage of egg yolk. This may be a function, for example, of perhaps a dilution effect of adding a protein-free cryoprotectant-containing sperm cell extender to a first cooled extended sperm cell mixture.
- the percentage of egg yolk contained within a second cooled extended sperm cell mixture may include more than about .4 percent egg yolk, more than about .8 percent egg yolk, more than about 1.6 percent egg yolk, or perhaps even more than about 3.2 percent egg yolk.
- Some embodiments may include a percentage of egg yolk contained with a second cooled extended sperm cell mixture of about 1.6 percent.
- Various embodiments may further involve decanting a portion of such a centrifuged second cooled extended sperm cell mixture.
- sperm cells concentrated by centrifugation may be concentrated largely within one area, and removing a volumetric section perhaps may include removing the volumetric section containing such concentrated sperm cells or perhaps even removing all volumetric sections not including such concentrated sperm cells.
- some embodiments may include a method for processing sorted sperm cells compromised by a sorting event.
- processing may be understood to include any event in which sperm cells are treated to change at least one characteristic of such sperm cells by at least some degree.
- processing may include for example freezing, thawing, or perhaps even centrifuging such sperm cells.
- embodiments may involve obtaining a plurality of sperm cells, subjecting such a plurality of sperm cells to sorting stresses, and selecting such a plurality of sperm cells for a desired characteristic. Some embodiments further may include providing a protein-free sperm cell extender, providing a protein-free cryoprotectant- containing sperm cell extender, and combining such a protein-free sperm cell extender with such a protein-free cryoprotectant-containing sperm cell extender to form a cryoprotectant-containing centrifugation medium.
- the term centrifugation medium may be understood to include any medium conducive to sperm cells that at some point is subjected to centrifugation.
- Various embodiments may further involve adding a plurality of sperm cells subjected to sorting stresses and selected for a desired characteristic to such an unclarified cryoprotectant-containing centrifugation medium, perhaps to form an unclarified cryoprotectant-containing sperm cell centrifugation medium.
- the term unclarified cryoprotectant-containing sperm cell centrifugation medium may be understood to include perhaps simply an unclarified cryoprotectant-containing centrifugation medium to which such a plurality of sperm cells has been added.
- certain embodiments may involve subjecting such an unclarified cryoprotectant-containing sperm cell centrifugation medium to centrifugation.
- centrifugation may be understood to include applying a centrifugal force to a substance in order to separate at least two constituent components of that substance based on density. This centrifugation may perhaps serve to concentrate sperm cells contained within such an unclarified cryoprotectant-containing sperm cell centrifugation medium, perhaps by separating such sperm cells from other components of the unclarified cryoprotectant-containing sperm cell centrifugation medium on a density basis due to the application of centrifugal force to the sperm cells.
- subjecting a protein-containing cyroprotectant-containing sperm cell centrifugation medium to centrifugation perhaps may include centrifuging such a protein-containing cyroprotectant-containing sperm cell centrifugation medium having a fraction of the percentage of egg yolk as compared to a centrifugation medium utilized in a typical method for centrifuging sorted sperm cells.
- Typical methods for centrifuging sorted sperm cells may be understood to include perhaps all methods for centrifuging sorted sperm cells not utilizing the novel techniques disclosed herein, and particularly may include perhaps those methods for centrifuging sorted sperm cells that may be well known in the art.
- various embodiments may include obtaining a plurality of sperm cells, subjecting such a plurality of sperm cells to sorting stresses, and selecting such a plurality of sperm cells for a desired characteristic.
- Embodiments may further include establishing a protein-containing sperm cell extender having a first protein content value.
- a first protein-content value may be understood to include the protein content of such an established protein-containing sperm cell extender prior to any subsequent events that may alter such a protein content.
- reducing a total protein content to a second protein content value below such a first protein content value may include reducing a percentage of egg yolk of such a protein-containing sperm cell extender. This may be a function, for example, of perhaps a dilution effect of adding a plurality of sperm cells and adding a protein-free sperm cell extender to such a protein-containing sperm cell extender.
- a percentage of egg yolk of a second protein content value may include more than about .4 percent egg yolk, more than about .8 percent egg yolk, more than about 1.6 percent egg yolk, or perhaps even more than about
- This centrifugation may perhaps serve to concentrate sperm cells contained within such a protein-containing sperm cell extender having a second protein content value, perhaps by separating such sperm cells from other components of a protein-containing sperm cell extender having a second protein content value on a density basis due to the application of centrifugal force to the sperm cells.
- Various embodiments may further involve decanting a portion of such a centrifuged protein-containing sperm cell extender having a second protein content value.
- sperm cells concentrated by centrifugation may be concentrated largely within one area, and removing a volumetric section perhaps may include removing the volumetric section containing such concentrated sperm cells or perhaps even removing all volumetric sections not including such concentrated sperm cells.
- Various embodiments may also include adding a supplemental protein-containing sperm cell extender to a protein-containing sperm cell extender having a second protein content value and increasing a total protein content of such a protein-containing sperm cell extender to a third protein content value higher than a first protein content value.
- supplemental protein-containing sperm cell extender may be understood to include any additional protein-containing sperm cell extender that supplements a protein- containing sperm cell extender having a second protein content value.
- the term supplement may be understood to include adding additional sperm cell extender components, for example perhaps adding an additional amount of protein.
- protein-containing sperm cell extender in various embodiments may be understood to include any sperm cell extender containing at least some degree of protein content.
- a protein-containing sperm cell extender may include perhaps plant-based protein content or perhaps animal-based protein content, which may be understood to include proteins derived from plant sources and animal sources respectively.
- an animal-based protein-containing sperm cell extender perhaps may include a lipoprotein-containing sperm cell extender. It may be appreciated that lipoproteins may be perhaps a subclass of proteins in which at least one component of such a protein is a lipid. Such a lipoprotein content may perhaps be derived from various animal sources, including perhaps egg yolk collected from various kinds of animal eggs, perhaps including hen's eggs.
- an egg yolk content of an egg-yolk-containing sperm cell extender may include less than about 50 percent egg yolk, less than about 45 percent egg yolk, less than about 40 percent egg yolk, less than about 35 percent egg yolk, less than about 30 percent egg yolk, less than about 25 percent egg yolk, less than about 20 percent egg yolk, less than about 15 percent egg yolk, less than about 10 percent egg yolk, or perhaps even less than about 5 percent egg yolk.
- an egg yolk content of an egg-yolk-containing sperm cell extender may be about 20 percent egg yolk.
- a cryoprotectant may be included as a constituent part of a sperm cell extender in various embodiments.
- a sperm cell extender in various embodiments may include perhaps a protein-free cryoprotectant-containing sperm cell extender or perhaps even a protein-containing cyroprotectant-containing sperm cell extender. It may be appreciated that various well-known cryoprotectants perhaps may be appropriate for such addition to a sperm cell extender. In various embodiments, such a cryoprotectant perhaps may include glycerol. It may be appreciated that the precise glycerol content of such a glycerol-containing sperm cell extender may be varied depending on the needs of a particular application for which sperm cells may be used.
- a glycerol-containing sperm cell extender may have more than about 3 percent glycerol, more than about 6 percent glycerol, more than about 12 percent glycerol, or perhaps even more than about 24 percent glycerol. In certain embodiments, a glycerol content of a glycerol-containing sperm cell extender may be about 6 percent.
- a protein-free cryoprotectant-containing sperm cell extender may be added to a substance in an equal volume to that substance, perhaps including accomplishing such an addition in multiple steps.
- adding a protein-free cryoprotectant-containing sperm cell extender to a first cooled extended sperm cell mixture may involve adding such a protein-free cryoprotectant-containing sperm cell extender having a volume equal to a volume of such a first cooled extended sperm cell mixture, perhaps in two or more steps.
- combining a protein-free cryoprotectant-containing sperm cell extender and a protein-free sperm cell extender may involve adding such a protein-free cryoprotectant-containing sperm cell extender in a volume equal to a volume of such a protein-free sperm cell extender, perhaps in two or more steps. Further, adding a protein-free cryoprotectant-containing sperm cell extender to a protein-containing sperm cell extender may involve adding such a protein-free cryoprotectant-containing sperm cell extender having a volume equal to a volume of such a protein-containing sperm cell extender, perhaps in two or more steps.
- a protein-free cryoprotectant-containing sperm cell extender in certain embodiments may include a low density gradient cryoprotectant-containing sperm cell extender. Accordingly, in some embodiments adding a protein-free cryoprotectant- containing sperm cell extender to a first cooled extended sperm cell mixture may involve adding a low density gradient cryoprotectant-containing sperm cell extender to such a first cooled extended sperm cell mixture. Further, in some embodiments providing a protein-free cryoprotectant-containing sperm cell extender may involve providing a low density gradient cryoprotectant-containing sperm cell extender.
- adding a protein-free cryoprotectant-containing sperm cell extender to a protein-containing sperm cell extender may involve adding a low density gradient cryoprotectant-containing sperm cell extender to such a protein-containing sperm cell extender.
- low density gradient may be understood to include a sperm cell extender having minimal density variations throughout its volume.
- a low density gradient cryoprotectant-containing sperm cell extender may perhaps include a substantially liquid cryoprotectant-containing sperm cell extender.
- substantially liquid may be understood to include a cryoprotectant-containing sperm cell extender wherein all constituent parts of such a cryoprotectant-containing sperm cell extender are in a substantially liquid state.
- a low density gradient cryoprotectant-containing sperm cell extender may perhaps include a centrifugation- efficient cryoprotectant-containing sperm cell extender.
- centrifugation-eff ⁇ cient may be understood to include a cryoprotectant-containing sperm cell extender having properties conducive to centrifugation, for example perhaps including clearly demarcated density differences in its constituent parts or perhaps even a lack of localized higher density regions that may pose a compaction risk to certain of its constituent parts.
- a low density gradient cryoprotectant-containing sperm cell extender may perhaps include a substantially uniform density cryoprotectant-containing sperm cell extender, which may be understood to include a minimal number of localized areas of higher density, perhaps even approaching no areas of localized higher density.
- a low density gradient cryoprotectant-containing sperm cell extender may perhaps include a cryoprotectant-containing sperm cell extender with substantially no sperm cell compaction particles.
- the term sperm cell compaction particle may be understood to include any particle or group of particles joined together that may tend to compact sperm cells to a damaging degree when subjected to various types of forces, perhaps including centrifugal forces.
- a low density gradient cryoprotectant-containing sperm cell extender may perhaps include a low viscosity cryoprotectant-containing sperm cell extender.
- the term low viscosity may be understood to include a viscosity of a cryoprotectant-containing sperm cell extender sufficient to permit its constituent parts to slip past each other without tending toward the compaction of any one constituent part by any other constituent part.
- Various embodiments may include adjusting a sperm cell concentration of a substance to a pre-freeze sperm cell concentration.
- pre-freeze sperm cell concentration may be understood to include a concentration of sperm cells at which such sperm cells may subsequently be frozen.
- some embodiments may involve adjusting a sperm cell concentration of a second cooled extended sperm cell mixture to a pre-freeze sperm cell concentration, while other embodiments may involve adjusting a sperm cell concentration of a protein-containing sperm cell extender having a second protein content value to a pre-freeze sperm cell concentration.
- adjusting to such a pre-freeze sperm cell concentration may include adding a protein- containing sperm cell extender, including for example perhaps adding a protein- containing sperm cell extender to a second extended sperm cell mixture or perhaps adding a supplemental protein-containing sperm cell extender to a protein-containing sperm cell extender having a second protein content value.
- a species-appropriate pre-freeze sperm cell concentration may include a bovine pre-freeze sperm cell concentration, an equine pre- freeze sperm cell concentration, a porcine pre-freeze sperm cell concentration, an ovine pre-freeze sperm cell concentration, a cervid pre-freeze sperm cell concentration, a canine pre-freeze sperm cell concentration, or perhaps even a delphinidae sperm cell concentration.
- a species-appropriate pre-freeze sperm cell concentration may include less than about 100 million sperm cells per milliliter, less than about 50 million sperm cells per milliliter, less than about 40 million sperm cells per milliliter, less than about 30 million sperm cells per milliliter, less than about 20 million sperm cells per milliliter, less than about 15 million sperm cells per milliliter, less than about 10 million sperm cells per milliliter, less than about 5 million sperm cells per milliliter, or perhaps even less than about 2 million sperm cells per milliliter.
- a species-appropriate pre-freeze concentration may be about 10 million sperm cells per milliliter.
- Adjusting a sperm cell concentration to a pre-freeze sperm cell concentration may include establishing a pre-freeze egg yolk content. For example, adjusting a sperm cell concentration of a second cooled extended sperm cell mixture to a pre-freeze sperm cell concentration may include establishing a pre-freeze egg yolk content of such second extended sperm cell mixture. Similarly, adjusting a sperm cell concentration of a protein-containing sperm cell extender having a second protein content value to a pre-freeze sperm cell concentration may include establishing a pre-freeze egg yolk content of such a protein-containing sperm cell extender.
- a pre-freeze egg yolk content perhaps may be established at an absolute value of less than about 50 percent egg yolk, less than about 45 percent egg yolk, less than about 40 percent egg yolk, less than about 35 percent egg yolk, less than about 30 percent egg yolk, less than about 25 percent egg yolk, less than about 20 percent egg yolk, less than about 15 percent egg yolk, or perhaps even less than about 10 percent egg yolk.
- a pre-freeze egg yolk content may be established at about 16.5 percent.
- a sterile sperm cell extender may be involved in certain embodiments.
- a protein-free sperm cell extender may include a sterile protein-free sperm cell extender, and a protein-free cryoprotectant-containing sperm cell extender may include a sterile protein-free cryoprotectant-containing sperm cell extender.
- an incipient admixture (1) may include an incipient compromised sorted sperm cell admixture.
- An admixture may be understood to include two or more substances in a state of being mixed, and an incipient admixture (1) may be understood to include an admixture that is less than completely saturated with respect to any two constituent components capable of being mixed.
- an incipient admixture (1) may include perhaps an admixture that has achieved less than 50 percent saturation, less than 25 percent saturation, less than 10 percent saturation, less than 5 percent saturation, less than 2 percent saturation, or perhaps even less than 1 percent saturation.
- admixture in some embodiments may include two or more nascent components, wherein such a component may be understood to be a component of an incipient admixture (1).
- various embodiments may include a nascent plurality of sperm cells selected for a desired characteristic (2) in incipient admixture relation, a nascent protein- free sperm cell extender component in incipient admixture relation (3), a nascent protein- free cryoprotectant-containing sperm cell extender component in incipient admixture relation (4), or perhaps even a nascent protein-containing sperm cell extender component in incipient admixture relation (5).
- a nascent substance may include a substance proximately located in a substantially uncombined state to at least one component of an incipient admixture (1).
- the term proximately located may be understood to include a location of such a nascent substance near enough to such a component of an incipient admixture (1) so as to permit a combination of the two.
- substantially uncombined state may be understood to include the existence of such a nascent substance in a state of mostly unsaturated combination with such a component of an incipient admixture (1), which may include perhaps existing as more than 50 percent uncombined, existing as more than 75 percent uncombined, existing as more than 90 percent uncombined, existing as more than 95 percent uncombined, or perhaps even existing as more than 99 percent uncombined.
- various embodiments may include a plurality of sperm cells selected for a desired characteristic proximately located in a substantially uncombined state to at least one component of an incipient admixture (1), a protein-free sperm cell extender component proximately located in a substantially uncombined state to at least one component of an incipient admixture (1), a protein-free cryoprotectant-containing sperm cell extender component proximately located in a substantially uncombined state to at least one component of an incipient admixture (1), or perhaps even a protein-containing sperm cell extender component proximately located in a substantially uncombined state to at least one component of an incipient admixture (1).
- Examples of an induced combination force may include perhaps a density- related force, a concentration-related force, or perhaps even simple hydrodynamic forces generated by placing various liquids in a container.
- the term responsive may be understood to include any effect on such a nascent substance or component of an incipient admixture (1) caused by such an induced combination force.
- an incipient admixture (1) in some embodiments may contain an egg yolk content. This may be a function, for example, of the amount of protein in a nascent protein-containing sperm cell extender component, perhaps wherein such protein may be egg yolk.
- the percentage of egg yolk contained within an incipient admixture may include more than about .4 percent egg yolk, more than about .8 percent egg yolk, more than about 1.6 percent egg yolk, or perhaps even more than about 3.2 percent egg yolk.
- Some embodiments may include a percentage of egg yolk contained with an incipient admixture (1) of about 1.6 percent.
- an incipient admixture (1) may include an unclarified incipient admixture (1).
- Various embodiments also may include a cool incipient admixture.
- a cool incipient admixture may be an incipient admixture (1) at a temperature of less than about 10 degrees Celsius, less than about 9 degrees Celsius, less than about 8 degrees Celsius, less than about 7 degrees Celsius, less than about 6 degrees Celsius, less than about 5 degrees Celsius, less than about 4 degrees Celsius, less than about 3 degrees Celsius, less than about 2 degrees Celsius, or perhaps even less than about 1 degree Celsius.
- a cool incipient admixture may be an admixture at about 5 degrees Celsius.
- some embodiments may include a compromised sorted sperm cell processing medium.
- processing medium may be understood to include any medium conducive to sperm cells in which sperm cells may be placed to undergo processing.
- embodiments also may include a plurality of sperm cells selected for a desired characteristic, an unclarified protein-free sperm cell extender component, an unclarified protein-free cryoprotectant-containing sperm cell extender component, and an unclarified centrifugation medium (7) in which said plurality of sperm cells selected for a desired characteristic, said unclarified protein-free sperm cell extender component, and said unclarified protein-free cryoprotectant-containing sperm cell extender component are suspended.
- Certain embodiments may further include an unclarified protein-containing sperm cell extender component suspended in an unclarified centrifugation medium (7).
- an unclarified centrifugation medium (7) in some embodiments may contain an egg yolk content. This may be a function, for example, of perhaps the amount of protein in such an unclarified protein-containing sperm cell extender component, perhaps wherein such protein may be egg yolk.
- the percentage of egg yolk contained within an unclarified centrifugation medium (7) may include more than about .4 percent egg yolk, more than about .8 percent egg yolk, more than about 1.6 percent egg yolk, or perhaps even more than about 3.2 percent egg yolk.
- an unclarified centrifugation medium (7) may perhaps include a cool unclarified centrifugation medium (7).
- a cool unclarified centrifugation medium (7) perhaps may include an unclarified centrifugation medium (7) at a temperature of less than about 10 degrees Celsius, less than about 9 degrees Celsius, less than about 8 degrees Celsius, less than about 7 degrees Celsius, less than about 6 degrees Celsius, less than about 5 degrees Celsius, less than about 4 degrees Celsius, less than about 3 degrees Celsius, less than about 2 degrees Celsius, or perhaps even less than about 1 degree Celsius.
- a cool unclarified centrifugation medium perhaps include a cool unclarified centrifugation medium (7) at a temperature of less than about 10 degrees Celsius, less than about 9 degrees Celsius, less than about 8 degrees Celsius, less than about 7 degrees Celsius, less than about 6 degrees Celsius, less than about 5 degrees Celsius, less than about 4 degrees Celsius, less than about 3 degrees Celsius, less than about 2 degrees Celsius, or perhaps even less than about 1 degree Celsius.
- an unclarified centrifugation medium (7) may include an unclarified centrifugation medium (7) at a temperature of about 5 degrees Celsius.
- an unclarified centrifugation medium (7) may perhaps have a minimized number of localized high density regions (6), including perhaps even no localized high density regions (6).
- the term localized may be understood to include a region of an unclarified centrifugation medium (7) that may be concentrated within a small volume of such an unclarified centrifugation medium (7), including perhaps a volume of less than 3 percent, less that 2 percent, less 1 percent, less than .05 percent, or perhaps even less than .01 percent of the total volume of an unclarified centrifugation medium (7).
- the term localized high density region (6) may be understood to include localized regions of an unclarified centrifugation medium (7) having a substantially higher density than surrounding regions, including perhaps more than 10 % of a surrounding density, more than 20 % of a surrounding density, more than 30 % of a surrounding density, more than 40 % of a surrounding density, more than 50 % of a surrounding density, more than 100 % of a surrounding density, more than 200 % of a surrounding density, more than 300 % of a surrounding density, more than 400 % of a surrounding density, or perhaps even more than 500 % of a surrounding density.
- certain embodiments may include an intermediate compromised sorted sperm cell extension medium.
- a sperm cell extension medium may be understood to include any medium conducive to sperm cells in which sperm cells may be placed for extension.
- the term intermediate may be understood to include a sperm cell extension medium representing an intermediate step in a process of treating sperm cells.
- such an intermediate step perhaps may include adding a cryoprotectant to a previously prepared sperm cell medium, adding protein content to a previously prepared sperm cell medium, or perhaps centrifuging a previously prepared sperm cell medium.
- further embodiments may include a plurality of sperm cells selected for a desired characteristic (8), a protein-free sperm cell extender component (9), a protein- free cryoprotectant-containing sperm cell extender component (10), and a protein- containing sperm cell extender component (11).
- Certain embodiments also may include a total protein content not exceeding about 1.6 percent (12). This may be a function, for example, of perhaps the amount of protein in a protein-containing sperm cell extender component of such an intermediate sperm cell extension medium.
- the protein in a protein-containing sperm cell extender perhaps may be egg yolk. Accordingly, a total protein content not exceeding about 1.6 percent perhaps may include an egg yolk content not exceeding about 1.6 percent.
- Certain embodiments may also include a cooled intermediate extension medium in which a plurality of sperm cells selected for a desired characteristic (8), protein-free sperm cell extender component (9), a protein-free cryoprotectant-containing sperm cell extender component (10), and a protein-containing sperm cell extender component (11) may be suspended.
- a cooled intermediate extension medium may include an intermediate extension medium at a temperature of perhaps less than about 10 degrees Celsius, less than about 9 degrees Celsius, less than about 8 degrees Celsius, less than about 7 degrees Celsius, less than about 6 degrees Celsius, less than about 5 degrees Celsius, less than about 4 degrees Celsius, less than about 3 degrees Celsius, less than about 2 degrees Celsius, or perhaps even less than about 1 degree Celsius.
- such a cooled intermediate extension medium may have a temperature of about 5 degrees Celsius.
- a protein-free cryoprotectant-containing sperm cell extender may not significantly adversely impact the effectiveness of a sperm cell extender in which it used.
- the use of such a sperm cell extender perhaps may yield results that are not significantly different than those achieved with the use of typical sperm cell extenders.
- pregnancy rates achieved with such a sperm cell extender in various embodiments perhaps may be comparable to those achieved with typical sperm cell extenders, including perhaps even being statistically comparable (P > 0.05) in various embodiments.
- Tris-A catch medium (2- ml) may be deposited in a 50-ml Falcon tube. Sorted sperm may be collected into the 50- ml Falcon tube over the course of approximately 1 hour for a total sorted volume of 12.5- ml. This volume may be non-glycerol containing and may be referred to as the A-fraction.
- This method of adding the glycerol- containing extender to cooled sperm may avoid over extension of sperm pellets that may occur when non-sperm containing droplets are perhaps collected in the sorting process, if the sperm pellet is left in too much volume, and may assure that the final glycerol content is always 6%.
- a 200- ⁇ l sperm pellet may remain after removal of the supernatant.
- Sperm pellets from the same male may be pooled and total volume may be determined by weight. The number of total sorted sperm may be determined, perhaps with multiple hemacytometer counts, and the sperm concentration of the pellet may be adjusted to a desired freezing concentration, perhaps with 20% egg yolk AB extender.
- a final glycerol concentration of 3 % resulted in statistically lower motilities at 30-min and 120-min after thawing, while motilities were higher and did not differ as a function ot 4-6% glycerol. See Chart 2. From this example, it perhaps may be concluded that 3% glycerol did not provide adequate cryoprotection for sorted sperm. Since motilities did not differ between 4-6% glycerol, and the provision of adequate cryoprotection may be desirable (which may differ between bulls), a final concentration of 6% glycerol for sex sorted sperm cryopreservation may be appropriate.
- Tubes containing sorted sperm were then centrifuged at 850 x g for 20-minutes at 5°C. Supernatant was removed, leaving sorted sperm in approximately 200- ⁇ l pellets. Like sperm pellets were pooled and adjusted to 10 x 10 6 sperm/ml with 20% egg yolk- AB medium (6% final glycerol content). Final egg yolk percentage in the product varied by sorting day (range: 16.5 - 18.2%).
- Sperm (2 x 10 6 ) were packaged into 0.25-ml coded straws to ensure treatments were blind to AI technicians, placed on freezing racks and cryopreserved in LN 2 vapor. An equal number of straws from each bull and treatment were placed into goblets and attached to aluminum canes.
- any claims set forth at any time are hereby incorporated by reference as part of this description of the invention, and the applicant expressly reserves the right to use all of or a portion of such incorporated content of such claims as additional description to support any of or all of the claims or any element or component thereof, and the applicant further expressly reserves the right to move any portion of or all of the incorporated content of such claims or any element or component thereof from the description into the claims or vice-versa as necessary to define the matter for which protection is sought by this application or by any subsequent continuation, division, or continuation-in-part application thereof, or to obtain any benefit of, reduction in fees pursuant to, or to comply with the patent laws, rules, or regulations of any country or treaty, and such content incorporated by reference shall survive during the entire pendency of this application including any subsequent continuation, division, or continuation-in-part application thereof or any reissue or extension thereon.
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2619951A CA2619951C (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing protein content in sperm cell extenders |
EP06800316.9A EP1924139B1 (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing protein content in sperm cell extenders |
ES06800316.9T ES2538979T3 (en) | 2005-07-29 | 2006-07-24 | Method and apparatus for reducing protein content in sperm cell extenders |
BRPI0614912-0A BRPI0614912B1 (en) | 2005-07-29 | 2006-07-24 | METHODS AND APPARATUS FOR REDUCING PROTEIN CONTENT IN SPERM CELL EXTENSORS |
DK06800316.9T DK1924139T3 (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing the protein content of sædcellestrækmidler |
NZ566129A NZ566129A (en) | 2005-07-29 | 2006-07-24 | Methods for freezing sorted sperm cells comprising a protein containing sperm cell extender and a protein free cryoprotectant before freezing |
MX2008001276A MX2008001276A (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing protein content in sperm cell extenders. |
BRPI0622294-3A BRPI0622294B1 (en) | 2005-07-29 | 2006-07-24 | MIXING OF INCIPIENTS |
JP2008524067A JP5394737B2 (en) | 2005-07-29 | 2006-07-24 | Method and apparatus for reducing protein content in sperm cell extenders |
AU2006275984A AU2006275984B2 (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing protein content in sperm cell extenders |
IL189638A IL189638A0 (en) | 2005-07-29 | 2008-02-20 | Methods and apparatus for reducing protein content in sperm cell extenders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400105P | 2005-07-29 | 2005-07-29 | |
US60/704,001 | 2005-07-29 | ||
US11/219,607 US7618770B2 (en) | 2005-07-29 | 2005-09-02 | Methods and apparatus for reducing protein content in sperm cell extenders |
US11/219,607 | 2005-09-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007016090A2 true WO2007016090A2 (en) | 2007-02-08 |
WO2007016090A3 WO2007016090A3 (en) | 2007-11-29 |
Family
ID=37694763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/028846 WO2007016090A2 (en) | 2005-07-29 | 2006-07-24 | Methods and apparatus for reducing protein content in sperm cell extenders |
Country Status (15)
Country | Link |
---|---|
US (2) | US7618770B2 (en) |
EP (1) | EP1924139B1 (en) |
JP (2) | JP5394737B2 (en) |
AR (1) | AR054180A1 (en) |
AU (1) | AU2006275984B2 (en) |
BR (2) | BRPI0614912B1 (en) |
CA (1) | CA2619951C (en) |
DK (1) | DK1924139T3 (en) |
ES (1) | ES2538979T3 (en) |
IL (1) | IL189638A0 (en) |
MX (1) | MX2008001276A (en) |
NZ (3) | NZ592269A (en) |
PT (1) | PT1924139E (en) |
UY (1) | UY29708A1 (en) |
WO (1) | WO2007016090A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
US7723116B2 (en) | 2003-05-15 | 2010-05-25 | Xy, Inc. | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US7758811B2 (en) | 2003-03-28 | 2010-07-20 | Inguran, Llc | System for analyzing particles using multiple flow cytometry units |
US7820425B2 (en) | 1999-11-24 | 2010-10-26 | Xy, Llc | Method of cryopreserving selected sperm cells |
US7833147B2 (en) | 2004-07-22 | 2010-11-16 | Inguran, LLC. | Process for enriching a population of sperm cells |
US7838210B2 (en) | 2004-03-29 | 2010-11-23 | Inguran, LLC. | Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations |
US7855078B2 (en) | 2002-08-15 | 2010-12-21 | Xy, Llc | High resolution flow cytometer |
US7929137B2 (en) | 1997-01-31 | 2011-04-19 | Xy, Llc | Optical apparatus |
WO2011143741A1 (en) * | 2010-05-15 | 2011-11-24 | Hopital Maisonneuve-Rosemont | Extenders for mammalian sperm processing and preservation |
US8137967B2 (en) | 2000-11-29 | 2012-03-20 | Xy, Llc | In-vitro fertilization systems with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US8211629B2 (en) | 2002-08-01 | 2012-07-03 | Xy, Llc | Low pressure sperm cell separation system |
US8426197B2 (en) | 2005-07-29 | 2013-04-23 | Xy, Llc | Methods and apparatus for reducing protein content in sperm cell extenders |
US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
US9145590B2 (en) | 2000-05-09 | 2015-09-29 | Xy, Llc | Methods and apparatus for high purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
US9365822B2 (en) | 1997-12-31 | 2016-06-14 | Xy, Llc | System and method for sorting cells |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071689A (en) * | 1997-12-31 | 2000-06-06 | Xy, Inc. | System for improving yield of sexed embryos in mammals |
NZ523569A (en) * | 2000-06-12 | 2005-11-25 | Colorado State University Thro | Integrated herd management system utilizing isolated populations of X-chromosome bearing and Y-chromosome bearing spermatozoa |
US20040031071A1 (en) * | 2000-10-05 | 2004-02-12 | Xy, Inc. | System of hysteroscopic insemination of mares |
US20060067916A1 (en) * | 2002-07-22 | 2006-03-30 | Xy, Inc. | Sperm cell process system |
US9888990B2 (en) | 2012-06-06 | 2018-02-13 | Inguran, Llc | Methods for use of sex sorted semen to improve genetic management in swine |
US9433195B2 (en) | 2012-06-06 | 2016-09-06 | Inguran, Llc | Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells |
JP7212886B2 (en) * | 2019-03-22 | 2023-01-26 | 国立研究開発法人産業技術総合研究所 | Method for producing sperm liquid for fertilization and method for producing frozen sperm straw |
CN110343615B (en) * | 2019-08-27 | 2023-05-23 | 浙江大学 | Culture dish for sperm-egg in-vitro combined fertilization and use method |
Family Cites Families (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3299354A (en) | 1962-07-05 | 1967-01-17 | Coulter Electronics | Aperture tube structure for particle study apparatus |
US3499435A (en) * | 1967-06-02 | 1970-03-10 | Paul E Rockwell | Esophageal probe for use in monitoring |
US3547526A (en) | 1967-10-26 | 1970-12-15 | Kollsman Instr Corp | Optical beam cross-section converter |
US3810010A (en) * | 1968-11-02 | 1974-05-07 | Telefunken Patent | Particle analysis method and apparatus wherein liquid containing particles is sucked into a constricted flow path |
US3829216A (en) | 1968-11-26 | 1974-08-13 | M Persidsky | Optical system and method for counting sperm cells |
US3894529A (en) | 1969-04-10 | 1975-07-15 | Bio Controls Inc | Method and means for controlling the sex of mammalian offspring and product therefor |
US4474875A (en) | 1969-04-10 | 1984-10-02 | Wallace Shrimpton | Method and means for controlling the sex of mammalian offspring and product therefor |
US4327177A (en) * | 1969-04-10 | 1982-04-27 | Wallace Shrimpton | Method and means for controlling the sex of mammalian offspring and product therefor |
US3687806A (en) | 1969-11-04 | 1972-08-29 | Bio Controls Inc | Method for controlling sex of mammalian offspring |
US3661460A (en) * | 1970-08-28 | 1972-05-09 | Technicon Instr | Method and apparatus for optical analysis of the contents of a sheathed stream |
US3644128A (en) * | 1970-12-28 | 1972-02-22 | Stuart Lipner | Method of preparing comminuted meat products |
US3756459A (en) | 1971-01-12 | 1973-09-04 | Damon Corp | Method and apparatus for metering fluid utilizing pressure differentials |
US3833796A (en) | 1971-10-13 | 1974-09-03 | Georgia Tech Res Inst | Method and apparatus for chromosome digitizing |
BE793185A (en) * | 1971-12-23 | 1973-04-16 | Atomic Energy Commission | APPARATUS FOR QUICKLY ANALYZING AND SORTING PARTICLES SUCH AS BIOLOGICAL CELLS |
US3826364A (en) | 1972-05-22 | 1974-07-30 | Univ Leland Stanford Junior | Particle sorting method and apparatus |
US3761941A (en) | 1972-10-13 | 1973-09-25 | Mead Corp | Phase control for a drop generating and charging system |
US4009260A (en) * | 1973-04-19 | 1977-02-22 | Schering Aktiengesellschaft | Fractionation of sperm |
USRE29141E (en) | 1973-06-14 | 1977-02-22 | Coulter Electronics, Inc. | Apparatus for orienting generally flat particles for sensing |
US3893766A (en) | 1973-06-14 | 1975-07-08 | Coulter Electronics | Apparatus for orienting generally flat particles for slit-scan photometry |
US3947093A (en) * | 1973-06-28 | 1976-03-30 | Canon Kabushiki Kaisha | Optical device for producing a minute light beam |
US3909744A (en) | 1973-09-24 | 1975-09-30 | United Technologies Corp | Unstable resonator system producing a high irradiance beam in the far field |
FR2254639B1 (en) | 1973-12-18 | 1978-06-02 | Agronomique Inst Nat Rech | |
US4070617A (en) * | 1974-05-08 | 1978-01-24 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Device for controlling the particle flow in an apparatus for measuring the properties of particles suspended in liquid |
US3973196A (en) | 1974-05-24 | 1976-08-03 | Coulter Electronics, Inc. | Method and apparatus for ejecting a metered amount of particulate sample |
US3963606A (en) | 1974-06-03 | 1976-06-15 | Coulter Electronics, Inc. | Semi-automatic adjusting delay for an electronic particle separator |
US3877430A (en) * | 1974-07-17 | 1975-04-15 | Horst K Wieder | Artificial insemination apparatus |
US4083957A (en) * | 1974-07-26 | 1978-04-11 | Lang John L | Process for the alteration of the sex-ratio of mammals |
US4092229A (en) * | 1975-12-17 | 1978-05-30 | Bhattacharya Bhairab C | Thermal convection counter streaming sedimentation and forced convection galvanization method for controlling the sex of mammalian offspring |
US3976197A (en) * | 1974-11-22 | 1976-08-24 | Bhattacharya Bhairab C | Thermal convection counter streaming sedimentation method and apparatus for controlling the sex of mammalian offspring |
USRE32350E (en) | 1974-11-22 | 1987-02-10 | Bhairab C. Bhattacharya | Thermal convection counter streaming sedimentation and forced convection galvanization method for controlling the sex of mammalian offspring |
US4014611A (en) * | 1975-04-30 | 1977-03-29 | Coulter Electronics, Inc. | Aperture module for use in particle testing apparatus |
US3960449A (en) | 1975-06-05 | 1976-06-01 | The Board Of Trustees Of Leland Stanford Junior University | Measurement of angular dependence of scattered light in a flowing stream |
US4007087A (en) * | 1975-10-17 | 1977-02-08 | Gametrics Limited | Sperm fractionation and storage |
AU2154077A (en) * | 1976-01-27 | 1978-07-27 | Univ Edinburgh | Control of sex ratio in mammalian offspring |
US4302166A (en) | 1976-04-22 | 1981-11-24 | Coulter Electronics, Inc. | Droplet forming apparatus for use in producing uniform particles |
US4162282A (en) | 1976-04-22 | 1979-07-24 | Coulter Electronics, Inc. | Method for producing uniform particles |
GB1583150A (en) | 1976-08-02 | 1981-01-21 | Milk Marketing Board | Apparatus for collecting eggs |
US4191749A (en) * | 1977-10-11 | 1980-03-04 | Bryant Bernard J | Method and material for increasing the percentage of mammalian offspring of either sex |
US4448767A (en) * | 1977-10-11 | 1984-05-15 | Sumar Corporation | Preparation of monospecific male-specific antibody and the use thereof for increasing the percentage of mammalian offspring of either sex |
US4179218A (en) | 1978-05-15 | 1979-12-18 | The Boeing Company | Particle size analyzer |
DE2832091A1 (en) | 1978-07-21 | 1980-01-31 | Eidenschink Henning | OPTICAL METHOD FOR DETERMINING THE PARTICLE SIZE OF COLLOIDAL SOLUTIONS AND MEASURING DEVICE FOR IMPLEMENTING THE METHOD |
US4276139A (en) | 1978-08-16 | 1981-06-30 | Lawson Rommon L | Process for magnetic separation and collection of viable female and male spermatozoa |
US4225405A (en) | 1978-08-16 | 1980-09-30 | Lawson Rommom L | Process for separation and collection of viable female and male spermatozoa |
US4230558A (en) | 1978-10-02 | 1980-10-28 | Coulter Electronics, Inc. | Single drop separator |
US4341471A (en) | 1979-01-02 | 1982-07-27 | Coulter Electronics, Inc. | Apparatus and method for measuring the distribution of radiant energy produced in particle investigating systems |
US4267268A (en) * | 1979-03-12 | 1981-05-12 | Nelson Jr Robert A | Spermatozoa extenders |
US4274408A (en) | 1979-03-26 | 1981-06-23 | Beatrice Nimrod | Method for guide-wire placement and novel syringe therefor |
US4200802A (en) * | 1979-03-28 | 1980-04-29 | The United States Of America As Represented By The United States Department Of Energy | Parabolic cell analyzer |
US4255021A (en) * | 1979-04-20 | 1981-03-10 | The United States Of America As Represented By The United States Department Of Energy | Optical device with conical input and output prism faces |
US4318482A (en) * | 1979-08-20 | 1982-03-09 | Ortho Diagnostics, Inc. | Method for measuring the velocity of a perturbed jetting fluid in an electrostatic particle sorting system |
US4318481A (en) * | 1979-08-20 | 1982-03-09 | Ortho Diagnostics, Inc. | Method for automatically setting the correct phase of the charge pulses in an electrostatic flow sorter |
US4317520A (en) * | 1979-08-20 | 1982-03-02 | Ortho Diagnostics, Inc. | Servo system to control the spatial position of droplet formation of a fluid jet in a cell sorting apparatus |
US4318480A (en) * | 1979-08-20 | 1982-03-09 | Ortho Diagnostics, Inc. | Method and apparatus for positioning the point of droplet formation in the jetting fluid of an electrostatic sorting device |
US4325483A (en) * | 1979-08-20 | 1982-04-20 | Ortho Diagnostics, Inc. | Method for detecting and controlling flow rates of the droplet forming stream of an electrostatic particle sorting apparatus |
DE2943116C2 (en) | 1979-10-25 | 1986-06-19 | Gesellschaft für Strahlen- und Umweltforschung mbH, 8000 München | Device for flow cytometric reaction and / or diffusion measurement |
US4400764A (en) | 1980-02-05 | 1983-08-23 | The Boeing Company | Low backscatter illumination system |
US4362246A (en) | 1980-07-14 | 1982-12-07 | Adair Edwin Lloyd | Method of treating collected mammal semen and separating sperm into X Y components |
US4350410A (en) | 1980-10-08 | 1982-09-21 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Multiprism collimator |
US4691829A (en) | 1980-11-03 | 1987-09-08 | Coulter Corporation | Method of and apparatus for detecting change in the breakoff point in a droplet generation system |
US4487320A (en) | 1980-11-03 | 1984-12-11 | Coulter Corporation | Method of and apparatus for detecting change in the breakoff point in a droplet generation system |
US4395676A (en) | 1980-11-24 | 1983-07-26 | Coulter Electronics, Inc. | Focused aperture module |
US4361400A (en) | 1980-11-26 | 1982-11-30 | The United States Of America As Represented By The United States Department Of Energy | Fluidic assembly for an ultra-high-speed chromosome flow sorter |
US4680258A (en) | 1981-03-24 | 1987-07-14 | Sloan-Kettering Institute For Cancer Research | Process for sex determination in man by use of monoclonal antibodies to the H-Y antigen |
US4818103A (en) * | 1981-05-15 | 1989-04-04 | Ratcom | Flow cytometry |
US4673288A (en) | 1981-05-15 | 1987-06-16 | Ratcom, Inc. | Flow cytometry |
US4339434A (en) | 1981-08-17 | 1982-07-13 | Gametrics Limited | Method of increasing the incidence of female offspring |
US4395397A (en) | 1981-09-17 | 1983-07-26 | Sidney Farber Cancer Institute, Inc. | Apparatus and method for killing unwanted cells |
US4422761A (en) | 1981-09-28 | 1983-12-27 | Frommer Joseph C | Photo-electric particle sensing system |
US4515274A (en) * | 1981-12-02 | 1985-05-07 | Coulter Corporation | Particle analyzing and sorting apparatus |
JPS59500340A (en) * | 1982-03-08 | 1984-03-01 | モトロ−ラ・インコ−ポレ−テツド | integrated circuit lead frame |
US4511661A (en) * | 1982-03-19 | 1985-04-16 | University Patents, Inc. | ATCC HB8116 And its monoclonal anti-H-Y antibody, Hyclonalan |
US4498766A (en) * | 1982-03-25 | 1985-02-12 | Becton, Dickinson And Company | Light beam focal spot elongation in flow cytometry devices |
US4559309A (en) | 1982-09-01 | 1985-12-17 | Memorial Sloan Kettering Cancer Center | Flow cytometry-fluorescence measurements for characterizing sperm |
US4501366A (en) * | 1982-12-14 | 1985-02-26 | Adolph Coors Company | Photomultiplier tube assembly |
JPS59143146A (en) * | 1983-02-07 | 1984-08-16 | Nippon Kogaku Kk <Nikon> | Mirror condenser type illuminating optical system |
US4523809A (en) | 1983-08-04 | 1985-06-18 | The United States Of America As Represented By The Secretary Of The Air Force | Method and apparatus for generating a structured light beam array |
US4538733A (en) | 1983-10-14 | 1985-09-03 | Becton, Dickinson And Company | Particle sorter with neutralized collection wells and method of using same |
US4573796A (en) * | 1984-01-06 | 1986-03-04 | The United States Of America As Represented By The United States Department Of Energy | Apparatus for eliminating background interference in fluorescence measurements |
US4631483A (en) | 1984-02-01 | 1986-12-23 | Coulter Electronics, Inc. | Particle analyzing apparatus and method of moving particles in suspension through such apparatus |
US4714680B1 (en) | 1984-02-06 | 1995-06-27 | Univ Johns Hopkins | Human stem cells |
US4600302A (en) | 1984-03-26 | 1986-07-15 | Becton, Dickinson And Company | Flow cytometry apparatus with uniform incoherent light excitation |
US4605558A (en) | 1984-04-20 | 1986-08-12 | Wallace Shrimpton | Process for cell separation |
US4660971A (en) * | 1984-05-03 | 1987-04-28 | Becton, Dickinson And Company | Optical features of flow cytometry apparatus |
FR2563726B1 (en) * | 1984-05-04 | 1986-10-10 | Robert Cassou | ARTIFICIAL INSEMINATION APPARATUS, PARTICULARLY CARNIVORES |
DE3580418D1 (en) | 1984-07-31 | 1990-12-13 | Hitachi Ltd | ELECTROPHORETIC SEPARATION PROCESS WITH FREE FLOW AND APPARATUS FOR THIS. |
ATE48477T1 (en) | 1984-09-11 | 1989-12-15 | Partec Ag | METHOD AND DEVICE FOR SORTING MICROSCOPIC PARTICLES. |
US4598408A (en) | 1984-10-22 | 1986-07-01 | Trw Inc. | High extraction efficiency cylindrical ring resonator |
US4702598A (en) | 1985-02-25 | 1987-10-27 | Research Corporation | Flow cytometer |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4744090A (en) * | 1985-07-08 | 1988-05-10 | Trw Inc. | High-extraction efficiency annular resonator |
US4794086A (en) | 1985-11-25 | 1988-12-27 | Liquid Air Corporation | Method for measurement of impurities in liquids |
US4999283A (en) * | 1986-01-10 | 1991-03-12 | University Of Kentucky Research Foundation | Method for x and y spermatozoa separation |
NL8601000A (en) * | 1986-04-21 | 1987-11-16 | Jan Greve T H Twente Afdeling | THE USE OF POLARIZED LIGHT IN FLOW CYTOMETRY. |
US4790653A (en) | 1986-05-22 | 1988-12-13 | Becton Dickinson And Company | Housing for a flow cytometry apparatus with particle unclogging feature |
US4780451B1 (en) | 1987-01-23 | 1995-04-04 | Asua International Inc | Composition and method for producing superovulation in cattle |
US4764013A (en) | 1987-03-23 | 1988-08-16 | The United States Of America As Represented By The United States Department Of Energy | Interferometric apparatus and method for detection and characterization of particles using light scattered therefrom |
EP0286088B1 (en) * | 1987-04-08 | 1994-09-14 | Hitachi, Ltd. | A sheath flow type flow-cell device |
JPS63262565A (en) * | 1987-04-20 | 1988-10-28 | Hitachi Ltd | Flow cell |
FR2614626B1 (en) * | 1987-04-30 | 1989-07-21 | Ranoux Claude | CONTAINER FOR FERTILIZATION OF OVOCYTES AND REPLACEMENT OF EMBRYOS IN HUMANS AND ANIMALS |
US4987539A (en) * | 1987-08-05 | 1991-01-22 | Stanford University | Apparatus and method for multidimensional characterization of objects in real time |
US4796788A (en) * | 1987-08-26 | 1989-01-10 | Liqui-Box Corporation | Bag-in-box packaging and dispensing of substances which will not readily flow by gravity |
US4758729A (en) | 1987-08-28 | 1988-07-19 | Spectra-Physics, Inc. | Apparatus and method for measuring the included angle of a reflective cone |
US4831385A (en) * | 1987-10-14 | 1989-05-16 | Burlington Industries, Inc. | Vacuum tray fluid-jet start-up system |
US4988619A (en) * | 1987-11-30 | 1991-01-29 | United States Department Of Energy | Flow cytometry apparatus |
US5622820A (en) * | 1988-03-10 | 1997-04-22 | City Of Hope | Method for amplification and detection of RNA and DNA sequences |
JPH0718785B2 (en) * | 1988-09-19 | 1995-03-06 | 株式会社日立製作所 | Flow cell device |
US4981580A (en) * | 1989-05-01 | 1991-01-01 | Coulter Corporation | Coincidence arbitration in a flow cytomery sorting system |
JPH0353164A (en) * | 1989-07-20 | 1991-03-07 | Canon Inc | Sample supply device and sample measuring instrument using the same |
US5098657A (en) * | 1989-08-07 | 1992-03-24 | Tsi Incorporated | Apparatus for measuring impurity concentrations in a liquid |
US5005981A (en) * | 1989-09-08 | 1991-04-09 | Becton, Dickinson And Company | Apparatus for method for causing vortices in a test tube |
JP2808321B2 (en) * | 1989-09-19 | 1998-10-08 | 東亜医用電子株式会社 | Cell analysis method and device |
EP0422616B1 (en) * | 1989-10-11 | 1996-02-07 | Canon Kabushiki Kaisha | Apparatus for and method of fractionating particle in particle-suspended liquid in conformity with the properties thereof |
US5101978A (en) * | 1989-11-27 | 1992-04-07 | The United States Of America As Represented By The Secretary Of The Army | Fluidic sorting device for two or more materials suspended in a fluid |
US5492534A (en) * | 1990-04-02 | 1996-02-20 | Pharmetrix Corporation | Controlled release portable pump |
US5840482A (en) * | 1990-10-10 | 1998-11-24 | The Regents Of The University Of California | Y chromosome specific nucleic acid probe and method for determining the Y chromosome in situ |
US5199576A (en) * | 1991-04-05 | 1993-04-06 | University Of Rochester | System for flexibly sorting particles |
DE9107792U1 (en) * | 1991-06-25 | 1991-09-12 | Labotect-Labor-Technik, Goettingen, Gmbh, 3406 Bovenden, De | |
US5298967A (en) * | 1992-06-02 | 1994-03-29 | Pacific Scientific Company | Measurement of concentrations of dissolved solvent |
US5315122A (en) * | 1992-08-25 | 1994-05-24 | Becton, Dickinson And Company | Apparatus and method for fluorescent lifetime measurement |
US5736410A (en) * | 1992-09-14 | 1998-04-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
JP2525713B2 (en) * | 1993-01-19 | 1996-08-21 | 農林水産省畜産試験場長 | Culture and transport method of bovine embryo using low molecular weight thiol compound |
US5494795A (en) * | 1993-05-05 | 1996-02-27 | The United States Of America As Represented By The Secretary Of The Navy | Specific oligonucleotide primers for detection of pathogenic campylobacter bacteria by polymerase chain reaction |
JPH08501718A (en) * | 1993-06-04 | 1996-02-27 | クワハック・インターナショナル・カンパニー・リミテッド | Artificial fertilization and fertilized egg transfer device |
US5483469A (en) * | 1993-08-02 | 1996-01-09 | The Regents Of The University Of California | Multiple sort flow cytometer |
US5596401A (en) * | 1993-09-16 | 1997-01-21 | Toa Medical Electronics Co., Ltd. | Particle analyzing apparatus using a coherence lowering device |
US5503994A (en) * | 1993-10-08 | 1996-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | System for sample detection with compensation for difference in sensitivity to detection of components moving at different velocities |
US5480774A (en) * | 1993-10-14 | 1996-01-02 | A/F Protein, Inc. | Determination of genomic sex in salmonids |
GB9324938D0 (en) * | 1993-12-04 | 1994-01-26 | Atomic Energy Authority Uk | Aerosol generator |
DE4419894A1 (en) * | 1994-06-07 | 1995-12-14 | Gip Medizin Technik Gmbh | Endoscopic puncture needle with elastic catheter |
US5891734A (en) * | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
US5602349A (en) * | 1994-10-14 | 1997-02-11 | The University Of Washington | Sample introduction system for a flow cytometer |
US5602039A (en) * | 1994-10-14 | 1997-02-11 | The University Of Washington | Flow cytometer jet monitor system |
US5514537A (en) * | 1994-11-28 | 1996-05-07 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Process and apparatus for sorting spermatozoa |
US5632754A (en) * | 1994-12-23 | 1997-05-27 | Devices For Vascular Intervention | Universal catheter with interchangeable work element |
FI98765C (en) * | 1995-01-16 | 1997-08-11 | Erkki Soini | Flow cytometric method and apparatus |
JP3584108B2 (en) * | 1996-01-08 | 2004-11-04 | キヤノン株式会社 | Lens barrel |
BR9600722A (en) * | 1996-02-14 | 1997-12-30 | Jorge Antonio Rodrigues Claro | Infusion pump for contained in flexible plastic bags |
US5895922A (en) * | 1996-03-19 | 1999-04-20 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Fluorescent biological particle detection system |
US5707808A (en) * | 1996-04-15 | 1998-01-13 | The Regents Of The University Of California | Optical selection and collection of DNA fragments |
JP2963393B2 (en) * | 1996-06-14 | 1999-10-18 | 浜松ホトニクス株式会社 | Voltage divider circuit for photomultiplier tube |
US5873254A (en) * | 1996-09-06 | 1999-02-23 | Interface Multigrad Technology | Device and methods for multigradient directional cooling and warming of biological samples |
US6534308B1 (en) * | 1997-03-27 | 2003-03-18 | Oncosis, Llc | Method and apparatus for selectively targeting specific cells within a mixed cell population |
US6050935A (en) * | 1997-05-09 | 2000-04-18 | Biofertec | Container assembly for intravaginal fertilization and culture and embryo transfer and method of intravaginal fertilization and culture employing such a container |
US5899848A (en) * | 1997-07-14 | 1999-05-04 | Haubrich; Mark A. | Device and process for artificial insemination of animals |
US5876942A (en) * | 1997-07-24 | 1999-03-02 | National Science Council Of Republic Of China | Process for sexing cow embryos |
US5895764A (en) * | 1997-11-24 | 1999-04-20 | University Of New Mexico | Controlled sheath flow injection cytometry |
US6149867A (en) * | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
US6071689A (en) * | 1997-12-31 | 2000-06-06 | Xy, Inc. | System for improving yield of sexed embryos in mammals |
US6175409B1 (en) * | 1999-04-02 | 2001-01-16 | Symyx Technologies, Inc. | Flow-injection analysis and variable-flow light-scattering methods and apparatus for characterizing polymers |
FR2789778B1 (en) * | 1999-02-12 | 2001-09-14 | France Telecom | METHOD FOR ASSOCIATING ROUTING REFERENCES WITH DATA PACKETS BY MEANS OF A SORTED MEMORY, AND PACKET ROUTER APPLYING THIS METHOD |
DE19935766A1 (en) * | 1999-07-29 | 2001-02-01 | Friedrich Schiller Uni Jena Bu | Process for the optical excitation of fluorophore-labeled DNA and RNA |
US7208265B1 (en) * | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
US6263745B1 (en) * | 1999-12-03 | 2001-07-24 | Xy, Inc. | Flow cytometer nozzle and flow cytometer sample handling methods |
NZ523911A (en) * | 2000-08-10 | 2005-03-24 | Gtc Biotherapeutics Inc | Cryopreservation of sperm |
US6673095B2 (en) * | 2001-02-12 | 2004-01-06 | Wound Healing Of Oklahoma, Inc. | Apparatus and method for delivery of laser light |
US7105355B2 (en) * | 2001-07-18 | 2006-09-12 | The Regents Of The University Of Michigan | Flow cytometers and detection system of lesser size |
WO2003064704A1 (en) * | 2002-01-28 | 2003-08-07 | Mds Proteomics, Inc. | Chemical proteomics |
US6698627B2 (en) * | 2002-02-19 | 2004-03-02 | Valois S.A.S. | Fluid dispenser |
US7618770B2 (en) * | 2005-07-29 | 2009-11-17 | Xy, Inc. | Methods and apparatus for reducing protein content in sperm cell extenders |
-
2005
- 2005-09-02 US US11/219,607 patent/US7618770B2/en active Active
-
2006
- 2006-07-24 PT PT68003169T patent/PT1924139E/en unknown
- 2006-07-24 NZ NZ592269A patent/NZ592269A/en unknown
- 2006-07-24 WO PCT/US2006/028846 patent/WO2007016090A2/en active Application Filing
- 2006-07-24 MX MX2008001276A patent/MX2008001276A/en active IP Right Grant
- 2006-07-24 AU AU2006275984A patent/AU2006275984B2/en active Active
- 2006-07-24 NZ NZ566129A patent/NZ566129A/en unknown
- 2006-07-24 CA CA2619951A patent/CA2619951C/en active Active
- 2006-07-24 JP JP2008524067A patent/JP5394737B2/en active Active
- 2006-07-24 NZ NZ592267A patent/NZ592267A/en unknown
- 2006-07-24 BR BRPI0614912-0A patent/BRPI0614912B1/en active IP Right Grant
- 2006-07-24 BR BRPI0622294-3A patent/BRPI0622294B1/en active IP Right Grant
- 2006-07-24 EP EP06800316.9A patent/EP1924139B1/en active Active
- 2006-07-24 ES ES06800316.9T patent/ES2538979T3/en active Active
- 2006-07-24 DK DK06800316.9T patent/DK1924139T3/en active
- 2006-07-27 AR ARP060103251A patent/AR054180A1/en not_active Application Discontinuation
- 2006-07-28 UY UY29708A patent/UY29708A1/en not_active Application Discontinuation
-
2008
- 2008-02-20 IL IL189638A patent/IL189638A0/en unknown
-
2009
- 2009-11-16 US US12/619,586 patent/US8426197B2/en active Active
-
2013
- 2013-01-21 JP JP2013008137A patent/JP2013066491A/en active Pending
Non-Patent Citations (2)
Title |
---|
None |
See also references of EP1924139A4 |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7929137B2 (en) | 1997-01-31 | 2011-04-19 | Xy, Llc | Optical apparatus |
US9422523B2 (en) | 1997-12-31 | 2016-08-23 | Xy, Llc | System and method for sorting cells |
US9365822B2 (en) | 1997-12-31 | 2016-06-14 | Xy, Llc | System and method for sorting cells |
US7820425B2 (en) | 1999-11-24 | 2010-10-26 | Xy, Llc | Method of cryopreserving selected sperm cells |
US10208345B2 (en) | 2000-05-09 | 2019-02-19 | Xy, Llc | Method for producing high purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
US9145590B2 (en) | 2000-05-09 | 2015-09-29 | Xy, Llc | Methods and apparatus for high purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
US8137967B2 (en) | 2000-11-29 | 2012-03-20 | Xy, Llc | In-vitro fertilization systems with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US9879221B2 (en) | 2000-11-29 | 2018-01-30 | Xy, Llc | Method of in-vitro fertilization with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US7771921B2 (en) | 2000-11-29 | 2010-08-10 | Xy, Llc | Separation systems of frozen-thawed spermatozoa into X-chromosome bearing and Y-chromosome bearing populations |
US8652769B2 (en) | 2000-11-29 | 2014-02-18 | Xy, Llc | Methods for separating frozen-thawed spermatozoa into X-chromosome bearing and Y-chromosome bearing populations |
US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
US8497063B2 (en) | 2002-08-01 | 2013-07-30 | Xy, Llc | Sex selected equine embryo production system |
US8211629B2 (en) | 2002-08-01 | 2012-07-03 | Xy, Llc | Low pressure sperm cell separation system |
US7855078B2 (en) | 2002-08-15 | 2010-12-21 | Xy, Llc | High resolution flow cytometer |
US11261424B2 (en) | 2002-09-13 | 2022-03-01 | Xy, Llc | Sperm cell processing systems |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
US8748183B2 (en) | 2003-03-28 | 2014-06-10 | Inguran, Llc | Method and apparatus for calibrating a flow cytometer |
US10100278B2 (en) | 2003-03-28 | 2018-10-16 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US8664006B2 (en) | 2003-03-28 | 2014-03-04 | Inguran, Llc | Flow cytometer apparatus and method |
US8709817B2 (en) | 2003-03-28 | 2014-04-29 | Inguran, Llc | Systems and methods for sorting particles |
US8709825B2 (en) | 2003-03-28 | 2014-04-29 | Inguran, Llc | Flow cytometer method and apparatus |
US11718826B2 (en) | 2003-03-28 | 2023-08-08 | Inguran, Llc | System and method for sorting particles |
US9040304B2 (en) | 2003-03-28 | 2015-05-26 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US7943384B2 (en) | 2003-03-28 | 2011-05-17 | Inguran Llc | Apparatus and methods for sorting particles |
US11104880B2 (en) | 2003-03-28 | 2021-08-31 | Inguran, Llc | Photo-damage system for sorting particles |
US9377390B2 (en) | 2003-03-28 | 2016-06-28 | Inguran, Llc | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US7799569B2 (en) | 2003-03-28 | 2010-09-21 | Inguran, Llc | Process for evaluating staining conditions of cells for sorting |
US7758811B2 (en) | 2003-03-28 | 2010-07-20 | Inguran, Llc | System for analyzing particles using multiple flow cytometry units |
US7723116B2 (en) | 2003-05-15 | 2010-05-25 | Xy, Inc. | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US7892725B2 (en) | 2004-03-29 | 2011-02-22 | Inguran, Llc | Process for storing a sperm dispersion |
US7838210B2 (en) | 2004-03-29 | 2010-11-23 | Inguran, LLC. | Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations |
US7833147B2 (en) | 2004-07-22 | 2010-11-16 | Inguran, LLC. | Process for enriching a population of sperm cells |
US8426197B2 (en) | 2005-07-29 | 2013-04-23 | Xy, Llc | Methods and apparatus for reducing protein content in sperm cell extenders |
WO2011143741A1 (en) * | 2010-05-15 | 2011-11-24 | Hopital Maisonneuve-Rosemont | Extenders for mammalian sperm processing and preservation |
Also Published As
Publication number | Publication date |
---|---|
DK1924139T3 (en) | 2015-05-18 |
BRPI0622294A2 (en) | 2014-10-29 |
IL189638A0 (en) | 2008-06-05 |
EP1924139A4 (en) | 2012-05-09 |
NZ592267A (en) | 2012-11-30 |
US8426197B2 (en) | 2013-04-23 |
AU2006275984A1 (en) | 2007-02-08 |
BRPI0622294B1 (en) | 2020-02-27 |
EP1924139B1 (en) | 2015-03-18 |
CA2619951A1 (en) | 2007-02-08 |
EP1924139A2 (en) | 2008-05-28 |
NZ566129A (en) | 2011-06-30 |
BRPI0614912A2 (en) | 2011-04-19 |
US7618770B2 (en) | 2009-11-17 |
UY29708A1 (en) | 2006-12-29 |
WO2007016090A3 (en) | 2007-11-29 |
MX2008001276A (en) | 2008-03-24 |
US20100216111A1 (en) | 2010-08-26 |
NZ592269A (en) | 2012-11-30 |
JP5394737B2 (en) | 2014-01-22 |
AR054180A1 (en) | 2007-06-06 |
CA2619951C (en) | 2018-09-04 |
AU2006275984B2 (en) | 2012-07-26 |
JP2013066491A (en) | 2013-04-18 |
PT1924139E (en) | 2015-07-16 |
JP2009502169A (en) | 2009-01-29 |
US20070026378A1 (en) | 2007-02-01 |
ES2538979T3 (en) | 2015-06-25 |
BRPI0614912B1 (en) | 2018-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7618770B2 (en) | Methods and apparatus for reducing protein content in sperm cell extenders | |
Jasko et al. | Effect of seminal plasma and egg yolk on motion characteristics of cooled stallion spermatozoa | |
CA2561681C (en) | Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa | |
SK7222002A3 (en) | Method of cryopreserving selected sperm cells | |
EP1730266A2 (en) | Sperm suspensions for sorting into x or y chromosome-bearing enriched populations | |
CA3049264C (en) | Sperm processing method, apparatus and related media compositions | |
WO2003022046A1 (en) | Method for cryopreserving mammalian cells and tissues | |
US20110105835A1 (en) | Method for preserving sperm and applications thereof | |
AU2012238290A1 (en) | Methods And Apparatus For Reducing Protein Content In Sperm Cell Extenders | |
RU2775530C2 (en) | Method for sperm treatment, device and related medium compositions | |
Said et al. | Effect of addition an amino acid or its combination with EDTA on DNA integrity and morphometry sperm heads of freeze-dried bovine spermatozoa. | |
Bhakat et al. | Effect of filtration of low grade ejaculates on semen quality parameters at refrigerated temperature (4–7 C) | |
Yıldız et al. | The Effects on Post-Thaw Sperm Quality and Nuclear DNA Integrity of Supplementation of Low-Density Lipoprotein to Freezing Extender in the Mouse | |
Bintara et al. | The comparison of Javanese bull and ongole crossbreed bull semen quality diluted with different diluents | |
Sriana et al. | The quality of frozen semen of Etawah crossbreed buck after washing by centrifugation | |
Costache | RESEARCHES OF SPERM CRYOPRESERVATION ON POLIODON (POLYODON SPATHULA) FOR OPTIMIZATION OF SPAWNING BIOTECHNOLOGY | |
Mukesh Bhakat et al. | Effect of filtration of low grade ejaculates on semen quality parameters at refrigerated temperature (4-7° C). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/001276 Country of ref document: MX Ref document number: 2008524067 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2619951 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 189638 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006275984 Country of ref document: AU Ref document number: 566129 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006800316 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006275984 Country of ref document: AU Date of ref document: 20060724 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0614912 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080129 |